Cutaneous manifestations of systemic disease

42
CUTANEOUS MANIFESTATIONS OF SYSTEMIC DISEASES

Transcript of Cutaneous manifestations of systemic disease

Page 1: Cutaneous manifestations of systemic disease

CUTANEOUS MANIFESTATIONS OF SYSTEMIC DISEASES

Page 2: Cutaneous manifestations of systemic disease
Page 3: Cutaneous manifestations of systemic disease

DUPUYTEN’S CONTRACTURE

• Fibromatous hyperplasia of the palmar aponeurosis, nodular thickening of fascia with associated flexion contractures of 1 or more digits.

• Familial,alcoholism, cirrhosis, epilepsy and diabetes mellitus,TB.

• Polyfibromatosis syndrome• Periarthritis of shoulder,chronic lung

disease,gout,trauma and ulnar nerve damage

Page 4: Cutaneous manifestations of systemic disease
Page 5: Cutaneous manifestations of systemic disease

DIABETIC DERMOPATHY(DIABETIC SHIN SPOTS)

• Shins, forearms, thighs, bony prominences

• Initial lesion oval dull red papule evolves slowly producing superficial scale, leaving an atrophic brownish scar.

Page 6: Cutaneous manifestations of systemic disease
Page 7: Cutaneous manifestations of systemic disease

THE DIABETICFOOT SYNDROME

• The cutaneous lesion is a plantar ulcer, often accompanied by soft tissue and bone infections which can require amputation.

• TRIGGERS include poorly fitting shoes, poor foot care, or overlooked foreign bodies, coupled with a structural foot deformity.

Page 8: Cutaneous manifestations of systemic disease

PATHOGENESIS OF DIABETIC FOOTSYNDROME

Page 9: Cutaneous manifestations of systemic disease

THERAPEUTIC GOALS

• The most important is optimal control of the diabetes mellitus

• Relieving pressure points and

• Avoiding or reducing callus formation

Page 10: Cutaneous manifestations of systemic disease

Association- 0.3 % of diabetic patients. Relatively asymptomatic lesions, F:M=3:1Characteristically found on the anterior and lateralsurfaces of the lower legs.

Page 11: Cutaneous manifestations of systemic disease

- Bullae appear spontaneously, usually on the extremities, especially the feet.- Heal in several weeks without significant scarring, although they may recur.

Page 12: Cutaneous manifestations of systemic disease
Page 13: Cutaneous manifestations of systemic disease

• Development of stiff, thick skin that resembles the changes in scleroderma

• Most apparent at acral sites, and may be associated with limited joint mobility (also known as cheirarthropathy) due to the abnormal collagen.

• The proposed mechanism is an increased cross-linking of collagen, known as non-enzymatic glycosylation (NEG), which produces stiffer collagen.

DIABETIC CHEIROARTHROPATHY

Page 14: Cutaneous manifestations of systemic disease
Page 15: Cutaneous manifestations of systemic disease
Page 16: Cutaneous manifestations of systemic disease
Page 17: Cutaneous manifestations of systemic disease
Page 18: Cutaneous manifestations of systemic disease
Page 19: Cutaneous manifestations of systemic disease

ACANTHOSIS NIGRICANS

• Cutaneous marker, most commonly of insulinresistance and less frequently of a malignancy.

• Hyperpigmented, hyperkeratotic, verrucous plaques that bestow a velvety texture on involved skin.

• Typically symmetric in distribution• Involves intertriginous areas, including the neck, axillae,

groin, antecubital and popliteal fossae, and umbilicus • Occasionally involves the oral, esophageal, pharyngeal,

laryngeal, conjunctival, and anogenital mucosae

Page 20: Cutaneous manifestations of systemic disease

INSULIN RESISTANCE–RELATED

OBESITY

ENDOCRINOPATHIES: acromegaly, cushing’s, hypo and hyperthyroidism, Polycystic ovarian disease (Stein-Leventhal syndrome)

MALIGNANCY-RELATED • Adenocarcinoma: gastric• Endocrine: phaeochromocytoma,testicular, thyroid,carcinoid• Melanoma, Sarcoma• Lung• Lymphomas • Other: cervical, urinary bladderDRUG-INDUCED: Testosterone, nicotinic acid, diethylstilbestrol, oral

contraceptives, triazinate, glucocorticoids, and with topical application of fusidic acid.

IDIOPATHIC• Familial• Nonfamilial

Page 21: Cutaneous manifestations of systemic disease
Page 22: Cutaneous manifestations of systemic disease

DIABETIC FINGER PEBBLES

• An exaggeration of the skin markings over the knuckles and on the dorsal aspect of the terminal phalanges.

• They are more cobblestoned than knuckle pads.

Page 23: Cutaneous manifestations of systemic disease

REACTIVE PERFORATING COLLAGENOSIS

Page 24: Cutaneous manifestations of systemic disease

SCLEROEDEMAAreas of induration frequently after infection, spontaneously clear in months or years.

Page 25: Cutaneous manifestations of systemic disease

CUTANEOUS FEATURES ASSOCIATED WITH DIABETES MELLITUS

• Infections• Peripheral vascular and small-vessel disease • Neuropathy • Pruritus• Necrobiosis lipoidica • Granuloma annulare variants • Perforating disorders • Xanthomas • Scleredema • Drug-related • Features of associated autoimmune disease

Page 26: Cutaneous manifestations of systemic disease
Page 27: Cutaneous manifestations of systemic disease
Page 28: Cutaneous manifestations of systemic disease
Page 29: Cutaneous manifestations of systemic disease

DIAMOND TRIAD

The combination of acropachy with

exophthalmos and pretibial myxedema.

Page 30: Cutaneous manifestations of systemic disease

PRETIBIAL MYXEDEMA

• Localized oedematous and thickened pretibial plaques

• 1-10% hyperthyroidism

• Erythema and slight edema are the early signs, with subsequent peau d'orange appearance as the degree of infiltration increases.

Page 31: Cutaneous manifestations of systemic disease

THYROID ACROPACHY

• Clubbing of fingers and toes in Grave’s disease associated with soft tissue swelling of hands and feet with periosteal new bone formation.

• A number of other causes, including bronchial neoplasia.

Page 32: Cutaneous manifestations of systemic disease

CUTANEOUS FEATURES RELATED TO ABNORMALITIES OF THYROID

HORMONE LEVELS (THYROTOXICOSIS)SKIN • Soft, smooth, velvety, warm, Palmar erythema, facial

flushing • Pruritus • Hyperpigmentation• Pretibial myxedema• May also be features of associated autoimmune

diseases, e.g. vitiligo, urticaria   SWEATING: Increased NAILS: Fast growth, Soft nails, koilonychia, distal

onycholysis,Thyroid acropachy HAIR: Fine thin hair, diffuse alopecia,Loss of pubic, axillary,

and facial hair,Loss of lateral eyebrowsORAL: Large tongue, gingival swelling, oral candidosis.

Page 33: Cutaneous manifestations of systemic disease
Page 34: Cutaneous manifestations of systemic disease

HERTOG’S SIGN

Page 35: Cutaneous manifestations of systemic disease
Page 36: Cutaneous manifestations of systemic disease

CUTANEOUS FEATURES RELATED TO ABNORMALITIES OF THYROID

HORMONE LEVELS (HYPOTHYROIDISM)SKIN • Pale, cold, scaly, wrinkled• Puffy edema of hands, face, and eyelids• Purpura and ecchymoses• Pruritus (due to xerosis or asteatotic eczema)• Ivory-yellow color (in part due to carotenemia)• Xanthomatosis (secondary to hyperlipidemia)SWEATING: DecreasedNAILS: Slow nail growth, brittle and striated nailsHAIR: Coarse hair, diffuse alopecia

Page 37: Cutaneous manifestations of systemic disease
Page 38: Cutaneous manifestations of systemic disease

ESTABLISH THE DIAGNOSIS AND RULE OUT DIFFERENTIAL DIAGNOSES

• PALPATE PURPURA

• CHECK TEMPERATURE and assess if patient is unwell

• Complete blood examination (CBC) platelets

• SKIN biopsy for HP&direct IF

Page 39: Cutaneous manifestations of systemic disease

D/D OF NONPALPABLE PURPURAI. PROCOAGULANT

DEFECT

A. Hemophilia

B. Anticoagulant use

C. Disseminated intravascular coagulation

D. Vitamin K deficiencyE. Hepatic insufficiency with

poor procoagulant synthesis

II. POOR DERMAL SUPPORT OF VESSELS

A. Actinic (senile) purpura

B. Glucocorticoid therapy, topical or systemic

C. Vitamin C deficiency (scurvy)

D. Systemic amyloidosis (light chain–related, some familial types)

E. Ehlers-Danlos syndrome (some types)

F. Pseudoxanthoma elasticum

Page 40: Cutaneous manifestations of systemic disease

IDENTIFY THE CAUSE

• pANCA• Streptococcal serology or throat swab

(especially in children)• Erythrocyte sedimentation rate (ESR), urea and

electrolytes (U&E), liver function tests (LFTs)OTHER INVESTIGATIONS• Findings on history including hepatitis serology,

rheumatoid factor, cryoglobulins, immunoglobulins, antinuclear factor (ANF), total complement levels and serum protein electrophoresis.

Page 41: Cutaneous manifestations of systemic disease

ASSESS THE EXTENT OF THE VASCULITIS

Further investigations should be directed toward

investigating relevant systems:

• RENAL – urinalysis looking for proteinuria and haematuria

• GASTROINTESTINAL – abdominal pain, gastrointestinal bleeding

• MUSCULOSKELETAL – nonerosive polyarthritis

• PULMONARY – pleural effusion

• CARDIAC – pericardial effusion.

Page 42: Cutaneous manifestations of systemic disease

MANAGEMENT

• General principles of management for vasculitis: Rest, elevation of the legs and compression hosiery.

• Systemic therapy indicated if the vasculitis is extensive, painful, ulcerating, or if there is renal involvement.

• The cause of the vasculitis should be managed as appropriate.